Skip to main content
Article thumbnail
Location of Repository

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy

By Joydeep Ghosh, Johnson Francis and Barry J. Maron

Abstract

Hypertrophic cardiomyopathy (HCM) is an important cardiovascular disease with sudden cardiac death as the most devastating presentation. Implantable cardioverter defibrillators (ICD) are the optimal therapy for prevention of sudden death from ventricular tachycardia or fibrillation of any cause. While there is no controversy with implanting ICDs in patients who have already survived a cardiac arrest, identifying high-risk patients for primary prevention in this disease remains a challenge. Implanting ICDs in patients with HCM is an important clinical consideration since many individuals could achieve normal or near-normal lifespans with this protection

Topics: Indian Pacing and Electrophysiology Journal
Publisher: Indian Pacing and Electrophysiology Group
Year: 2005
OAI identifier: oai:cogprints.org:4214
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://cogprints.org/4214/2/gh... (external link)
  • http://cogprints.org/4214/1/gh... (external link)
  • http://cogprints.org/4214/ (external link)
  • Suggested articles

    Citations

    1. (1999). Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation.
    2. (1999). Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA.
    3. (2003). Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol.
    4. (2000). Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    5. (2000). Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large nonreferral-based patient population. Circulation.
    6. (2004). Longterm follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy.
    7. (1995). Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation.
    8. (2004). Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient? Circulation.
    9. (2000). Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol.
    10. (2005). The Lead Extractor's Toolbox: A Review Of Current Endovascular Pacemaker And ICD Lead Extraction Techniques. Indian Pacing Electrophysiol.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.